{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:33:10Z","timestamp":1789450390112,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Periprosthetic Joint Infection (PJI) following hip and knee arthroplasty is a catastrophic complication in orthopaedic surgery. It has long been a key focus for orthopaedic surgeons in terms of prevention and management. With the increasing incidence of antibiotic resistance in recent years, finding more targeted treatment methods has become an increasingly urgent issue. Bacteriophage Therapy (BT) has emerged as a promising adjunctive treatment for bone and joint infections in recent years. It not only effectively kills bacteria but also demonstrates significant anti-biofilm activity, garnering substantial clinical interest due to its demonstrated efficacy and relatively low incidence of adverse effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This review aims to systematically evaluate the efficacy and safety of bacteriophage therapy in treating PJI following hip and knee arthroplasty, providing additional reference for its future clinical application.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Following predefined inclusion and exclusion criteria, our team conducted a systematic literature search across seven databases (PubMed, Embase, Web of Science, Cochrane Library, ClinicalTrials.gov, CNKI, and WanFang Database). The search was conducted up to May 2024 and included multiple clinical studies on the use of bacteriophage therapy for treating PJI after hip and knee arthroplasty to assess its efficacy and safety.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This systematic review included 16 clinical studies after screening, consisting of 15 case reports and one prospective controlled clinical trial, involving a total of 42 patients with PJI treated with bacteriophage therapy. The average patient age was 62.86 years, and 43 joints were treated, with patients undergoing an average of 5.25 surgeries. The most common pathogen in these infections was <jats:italic>Staphylococcus aureus<\/jats:italic>, accounting for 18 cases. 33 patients received cocktail therapy, while nine were treated with a single bacteriophage preparation. Additionally, all patients underwent suppressive antibiotic therapy (SAT) postoperatively. All patients were followed up for an average of 13.55 months. There were two cases of recurrence, one of which resulted in amputation one year postoperatively. The remaining patients showed good recovery outcomes. Overall, the results from the included studies indicate that bacteriophage therapy effectively eradicates infectious strains in various cases of PJI, with minimal side effects, demonstrating promising clinical efficacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In the treatment of PJI following hip and knee arthroplasty, bacteriophages, whether used alone or in combination as cocktail therapy, have shown therapeutic potential. However, thorough preoperative evaluation is essential, and appropriate bacteriophage types and treatment regimens must be selected based on bacteriological evidence. Future large-scale, randomized controlled, and prospective trials are necessary to validate the efficacy and safety of this therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00264-024-06295-1","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T08:05:26Z","timestamp":1725955526000},"page":"2809-2825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Bacteriophage therapy as an innovative strategy for the treatment of Periprosthetic Joint Infection: a systematic review"],"prefix":"10.1007","volume":"48","author":[{"given":"Shengdong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assala Abu","family":"Mukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed","family":"Abdelatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Batailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"6295_CR1","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.arth.2015.03.035","volume":"30","author":"AF Kamath","year":"2015","unstructured":"Kamath AF, Ong KL, Lau E et al (2015) Quantifying the Burden of Revision Total Joint Arthroplasty for Periprosthetic Infection. J Arthroplasty 30:1492\u20131497. https:\/\/doi.org\/10.1016\/j.arth.2015.03.035","journal-title":"J Arthroplasty"},{"key":"6295_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1302\/0301-620X.105B3.BJJ-2022-0800.R1","volume":"105\u2013B","author":"R Sangaletti","year":"2023","unstructured":"Sangaletti R, Zanna L, Akkaya M et al (2023) Periprosthetic joint infection in patients with multiple arthroplasties. Bone Joint J 105\u2013B:294\u2013300. https:\/\/doi.org\/10.1302\/0301-620X.105B3.BJJ-2022-0800.R1","journal-title":"Bone Joint J"},{"key":"6295_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00264-024-06171-y","volume":"48","author":"H Zhao","year":"2024","unstructured":"Zhao H, Li L, Wang H-Y et al (2024) Efficacy analysis of clinical serological indicators in the diagnosis of postoperative periprosthetic joint infection in patients with rheumatoid arthritis or osteoarthritis. Int Orthop 48:1945\u20131952. https:\/\/doi.org\/10.1007\/s00264-024-06171-y","journal-title":"Int Orthop"},{"key":"6295_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00264-024-06152-1","volume":"48","author":"C Yang","year":"2024","unstructured":"Yang C, Ji B, Li G et al (2024) Ninety-day postoperative mortality and complications in continuous and unselected single-stage revisions for chronic periprosthetic joint infection. Int Orthop 48:1691\u20131700. https:\/\/doi.org\/10.1007\/s00264-024-06152-1","journal-title":"Int Orthop"},{"key":"6295_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jor.25723","volume":"42","author":"N Piuzzi","year":"2024","unstructured":"Piuzzi N, Klika A, Lu Q et al (2024) Periprosthetic joint infection and immunity: current understanding of host-microbe interplay. J Orthop Res 42:7\u201320. https:\/\/doi.org\/10.1002\/jor.25723","journal-title":"J Orthop Res"},{"key":"6295_CR6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.arth.2020.12.005","volume":"36","author":"A Premkumar","year":"2021","unstructured":"Premkumar A, Kolin DA, Farley KX et al (2021) Projected Economic Burden of Periprosthetic Joint Infection of the hip and knee in the United States. J Arthroplasty 36:1484\u20131489e3. https:\/\/doi.org\/10.1016\/j.arth.2020.12.005","journal-title":"J Arthroplasty"},{"key":"6295_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12178-018-9500-5","volume":"11","author":"M Taha","year":"2018","unstructured":"Taha M, Abdelbary H, Ross F, Carli A (2018) New innovations in the treatment of PJI and Biofilms-Clinical and preclinical topics. Curr Rev Musculoskelet Med 11:380\u2013388. https:\/\/doi.org\/10.1007\/s12178-018-9500-5","journal-title":"Curr Rev Musculoskelet Med"},{"key":"6295_CR8","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1038\/s41467-023-39370-z","volume":"14","author":"T K\u00f6hler","year":"2023","unstructured":"K\u00f6hler T, Luscher A, Falconnet L et al (2023) Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa. Nat Commun 14:3629. https:\/\/doi.org\/10.1038\/s41467-023-39370-z","journal-title":"Nat Commun"},{"key":"6295_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","volume":"21","author":"L Leitner","year":"2021","unstructured":"Leitner L, Ujmajuridze A, Chanishvili N et al (2021) Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. Lancet Infect Dis 21:427\u2013436. https:\/\/doi.org\/10.1016\/S1473-3099(20)30330-3","journal-title":"Lancet Infect Dis"},{"key":"6295_CR10","doi-asserted-by":"publisher","first-page":"1243824","DOI":"10.3389\/fphar.2023.1243824","volume":"14","author":"AV Johri","year":"2023","unstructured":"Johri AV, Johri P, Hoyle N et al (2023) Case report: successful treatment of recurrent E. Coli infection with bacteriophage therapy for patient suffering from chronic bacterial prostatitis. Front Pharmacol 14:1243824. https:\/\/doi.org\/10.3389\/fphar.2023.1243824","journal-title":"Front Pharmacol"},{"key":"6295_CR11","doi-asserted-by":"publisher","unstructured":"Karn SL, Bhartiya SK, Pratap A et al (2024) A Randomized, Placebo-controlled, double-blind clinical trial of bacteriophage cocktails in chronic wound infections. Int J Low Extrem Wounds 15347346231226342. https:\/\/doi.org\/10.1177\/15347346231226342","DOI":"10.1177\/15347346231226342"},{"key":"6295_CR12","doi-asserted-by":"publisher","first-page":"121206","DOI":"10.1016\/j.ijpharm.2021.121206","volume":"609","author":"D Khanal","year":"2021","unstructured":"Khanal D, Chang RYK, Hick C et al (2021) Enteric-coated bacteriophage tablets for oral administration against gastrointestinal infections. Int J Pharm 609:121206. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121206","journal-title":"Int J Pharm"},{"key":"6295_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/EOR-24-0042","volume":"9","author":"T Ferry","year":"2024","unstructured":"Ferry T, Onsea J, Roussel-Gaillard T et al (2024) Bacteriophage therapy in musculoskeletal infections: from basic science to clinical application. EFORT Open Rev 9:339\u2013348. https:\/\/doi.org\/10.1530\/EOR-24-0042","journal-title":"EFORT Open Rev"},{"key":"6295_CR14","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","volume":"22","author":"S Uyttebroek","year":"2022","unstructured":"Uyttebroek S, Chen B, Onsea J et al (2022) Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect Dis 22:e208\u2013e220. https:\/\/doi.org\/10.1016\/S1473-3099(21)00612-5","journal-title":"Lancet Infect Dis"},{"key":"6295_CR15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/jor.25167","volume":"40","author":"K Suster","year":"2022","unstructured":"Suster K, C\u00f6r A (2022) Fast and specific detection of staphylococcal PJI with bacteriophage-based methods within 104 sonicate fluid samples. J Orthop Res 40:1358\u20131364. https:\/\/doi.org\/10.1002\/jor.25167","journal-title":"J Orthop Res"},{"key":"6295_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2106\/JBJS.21.00958","volume":"104","author":"B DePalma","year":"2022","unstructured":"DePalma B, Nandi S, Chaudhry W et al (2022) Assessment of Staphylococcal Clinical isolates from Periprosthetic Joint Infections for potential bacteriophage therapy. J BONE JOINT SURGERY-AMERICAN VOLUME 104:693\u2013699. https:\/\/doi.org\/10.2106\/JBJS.21.00958","journal-title":"J BONE JOINT SURGERY-AMERICAN VOLUME"},{"key":"6295_CR17","doi-asserted-by":"publisher","unstructured":"Kaur S, Harjai K, Chhibber S (2016) In vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) mediated Orthopaedic device related infections. https:\/\/doi.org\/10.1371\/journal.pone.0157626. PLOS ONE 11:","DOI":"10.1371\/journal.pone.0157626"},{"key":"6295_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1302\/0301-620X.102B7.BJJ-2019-1590.R1","volume":"102B","author":"B Sosa","year":"2020","unstructured":"Sosa B, Niu V, Turajane K et al (2020) 2020 John Charnley Award: the antimicrobial potential of bacteriophage-derived lysin in a murine debridement, antibiotics, and implant retention model of prosthetic joint infection. BONE JOINT J 102B:3\u201310. https:\/\/doi.org\/10.1302\/0301-620X.102B7.BJJ-2019-1590.R1","journal-title":"BONE JOINT J"},{"key":"6295_CR19","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"6295_CR20","doi-asserted-by":"publisher","first-page":"ofy269","DOI":"10.1093\/ofid\/ofy269","volume":"5","author":"T Ferry","year":"2018","unstructured":"Ferry T, Leboucher G, Fevre C et al (2018) Salvage Debridement, Antibiotics and Implant Retention (DAIR) with local injection of a selected cocktail of bacteriophages: is it an option for an Elderly Patient with Relapsing Staphylococcus aureus Prosthetic-Joint infection? Open Forum Infect Dis 5:ofy269. https:\/\/doi.org\/10.1093\/ofid\/ofy269","journal-title":"Open Forum Infect Dis"},{"key":"6295_CR21","doi-asserted-by":"publisher","unstructured":"Patey O, McCallin S, Mazure H et al (2018) Clinical indications and compassionate use of phage therapy: personal experience and literature review with a focus on Osteoarticular infections. https:\/\/doi.org\/10.3390\/v11010018. Viruses 11:","DOI":"10.3390\/v11010018"},{"key":"6295_CR22","doi-asserted-by":"publisher","unstructured":"Tkhilaishvili T, Winkler T, M\u00fcller M et al (2019) Bacteriophages as adjuvant to antibiotics for the Treatment of Periprosthetic Joint Infection caused by Multidrug-Resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 64. https:\/\/doi.org\/10.1128\/AAC.00924-19","DOI":"10.1128\/AAC.00924-19"},{"key":"6295_CR23","doi-asserted-by":"publisher","unstructured":"Doub JB, Ng VY, Johnson AJ et al (2020) Salvage bacteriophage therapy for a chronic MRSA prosthetic joint infection. Antibiotics 9. https:\/\/doi.org\/10.3390\/antibiotics9050241","DOI":"10.3390\/antibiotics9050241"},{"key":"6295_CR24","doi-asserted-by":"publisher","unstructured":"Ferry T, Kolenda C, Batailler C et al (2020) Phage therapy as adjuvant to conservative surgery and antibiotics to salvage patients with relapsing S. Aureus prosthetic knee infection. Front Med 7. https:\/\/doi.org\/10.3389\/fmed.2020.570572","DOI":"10.3389\/fmed.2020.570572"},{"key":"6295_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fmed.2020.00342","volume":"7","author":"T Ferry","year":"2020","unstructured":"Ferry T, Batailler C, Petitjean C et al (2020) The potential innovative use of bacteriophages within the DAC(\u00ae) hydrogel to treat patients with knee megaprosthesis infection requiring Debridement antibiotics and Implant Retention and Soft tissue Coverage as Salvage Therapy. Front Med (Lausanne) 7:342. https:\/\/doi.org\/10.3389\/fmed.2020.00342","journal-title":"Front Med (Lausanne)"},{"key":"6295_CR26","doi-asserted-by":"publisher","first-page":"E144","DOI":"10.1093\/cid\/ciaa705","volume":"73","author":"EJ Cano","year":"2021","unstructured":"Cano EJ, Caflisch KM, Bollyky PL et al (2021) Phage therapy for limb-threatening prosthetic knee Klebsiella pneumoniae infection: Case Report and in Vitro characterization of anti-biofilm activity. Clin Infect Dis 73:E144\u2013E151. https:\/\/doi.org\/10.1093\/cid\/ciaa705","journal-title":"Clin Infect Dis"},{"key":"6295_CR27","doi-asserted-by":"publisher","unstructured":"Doub JB, Ng VY, Wilson E et al (2021) Successful treatment of a recalcitrant staphylococcus epidermidis prosthetic knee infection with intraoperative bacteriophage therapy. Pharmaceuticals 14. https:\/\/doi.org\/10.3390\/ph14030231","DOI":"10.3390\/ph14030231"},{"key":"6295_CR28","doi-asserted-by":"publisher","first-page":"569159","DOI":"10.3389\/fmed.2021.569159","volume":"8","author":"T Ferry","year":"2021","unstructured":"Ferry T, Kolenda C, Batailler C et al (2021) Case Report: arthroscopic debridement antibiotics and Implant Retention with Local Injection of Personalized Phage Therapy to Salvage a Relapsing Pseudomonas Aeruginosa prosthetic knee infection. Front Med (Lausanne) 8:569159. https:\/\/doi.org\/10.3389\/fmed.2021.569159","journal-title":"Front Med (Lausanne)"},{"key":"6295_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1080\/17453674.2021.1968714","volume":"92","author":"A-S Neuts","year":"2021","unstructured":"Neuts A-S, Berkhout HJ, Hartog A, Goosen JHM (2021) Bacteriophage therapy cures a recurrent Enterococcus faecalis infected total hip arthroplasty? A case report. Acta Orthop 92:678\u2013680. https:\/\/doi.org\/10.1080\/17453674.2021.1968714","journal-title":"Acta Orthop"},{"key":"6295_CR30","doi-asserted-by":"publisher","unstructured":"Ramirez-Sanchez C, Gonzales F, Buckley M et al (2021) Successful treatment of staphylococcus aureus prosthetic joint infection with bacteriophage therapy. Viruses 13. https:\/\/doi.org\/10.3390\/v13061182","DOI":"10.3390\/v13061182"},{"key":"6295_CR31","doi-asserted-by":"publisher","unstructured":"Schoeffel J, Wang EW, Gill D et al (2022) Successful use of salvage bacteriophage therapy for a recalcitrant MRSA knee and hip prosthetic joint infection. Pharmaceuticals 15. https:\/\/doi.org\/10.3390\/ph15020177","DOI":"10.3390\/ph15020177"},{"key":"6295_CR32","doi-asserted-by":"publisher","unstructured":"Racenis K, Rezevska D, Madelane M et al (2022) Use of phage cocktail BFC 1.10 in Combination with Ceftazidime-Avibactam in the treatment of Multidrug-Resistant Pseudomonas aeruginosa Femur Osteomyelitis\u2014A Case Report. Front Med 9. https:\/\/doi.org\/10.3389\/fmed.2022.851310","DOI":"10.3389\/fmed.2022.851310"},{"key":"6295_CR33","doi-asserted-by":"publisher","unstructured":"Cesta N, Pini M, Mulas T et al (2023) Application of phage therapy in a case of a chronic hip-prosthetic joint infection due to Pseudomonas aeruginosa: an Italian real-life experience and in Vitro Analysis. Open Forum Infect Dis 10. https:\/\/doi.org\/10.1093\/ofid\/ofad051","DOI":"10.1093\/ofid\/ofad051"},{"key":"6295_CR34","doi-asserted-by":"publisher","unstructured":"Fedorov E, Samokhin A, Kozlova Y et al (2023) Short-term outcomes of phage-antibiotic combination treatment in adult patients with periprosthetic hip joint infection. Viruses 15. https:\/\/doi.org\/10.3390\/v15020499","DOI":"10.3390\/v15020499"},{"key":"6295_CR35","doi-asserted-by":"publisher","first-page":"e01854","DOI":"10.1016\/j.idcr.2023.e01854","volume":"33","author":"JB Doub","year":"2023","unstructured":"Doub JB, Chan B, Johnson AJ (2023) Salphage: salvage bacteriophage therapy for a chronic Enterococcus faecalis prosthetic joint infection. IDCases 33:e01854. https:\/\/doi.org\/10.1016\/j.idcr.2023.e01854","journal-title":"IDCases"},{"key":"6295_CR36","doi-asserted-by":"publisher","unstructured":"Limoli DH, Jones CJ, Wozniak DJ (2015) Bacterial extracellular polysaccharides in Biofilm formation and function. https:\/\/doi.org\/10.1128\/microbiolspec.MB-0011-2014. Microbiol Spectr 3:","DOI":"10.1128\/microbiolspec.MB-0011-2014"},{"key":"6295_CR37","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/jor.25345","volume":"40","author":"A Visperas","year":"2022","unstructured":"Visperas A, Santana D, Klika AK et al (2022) Current treatments for biofilm-associated periprosthetic joint infection and new potential strategies. J Orthop Res 40:1477\u20131491. https:\/\/doi.org\/10.1002\/jor.25345","journal-title":"J Orthop Res"},{"key":"6295_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijantimicag.2013.02.018","volume":"41","author":"D Molina-Manso","year":"2013","unstructured":"Molina-Manso D, del Prado G, Ortiz-P\u00e9rez A et al (2013) In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Int J Antimicrob Agents 41:521\u2013523. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.02.018","journal-title":"Int J Antimicrob Agents"},{"key":"6295_CR39","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.disamonth.2020.100971","volume":"66","author":"MA Abushaheen","year":"2020","unstructured":"Abushaheen MA, Muzaheed, Fatani AJ et al (2020) Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon 66:100971. https:\/\/doi.org\/10.1016\/j.disamonth.2020.100971","journal-title":"Dis Mon"},{"key":"6295_CR40","doi-asserted-by":"publisher","unstructured":"Ghosh D, Veeraraghavan B, Elangovan R, Vivekanandan P (2020) Antibiotic resistance and epigenetics: more to it than meets the Eye. Antimicrob Agents Chemother 64. https:\/\/doi.org\/10.1128\/AAC.02225-19","DOI":"10.1128\/AAC.02225-19"},{"key":"6295_CR41","unstructured":"(2022) Global Antimicrobial Resistance and Use Surveillance System (GLASS) report 2022. World Health Organization"},{"key":"6295_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1302\/2046-3758.111.BJR-2021-0499","volume":"11","author":"N Walter","year":"2022","unstructured":"Walter N, Rupp M, Baertl S et al (2022) Periprosthetic joint infection: patients benefit from a multidisciplinary team approach. Bone Joint Res 11:8\u20139. https:\/\/doi.org\/10.1302\/2046-3758.111.BJR-2021-0499","journal-title":"Bone Joint Res"},{"key":"6295_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","volume":"387","author":"BH Kapadia","year":"2016","unstructured":"Kapadia BH, Berg RA, Daley JA et al (2016) Periprosthetic joint infection. Lancet 387:386\u2013394. https:\/\/doi.org\/10.1016\/S0140-6736(14)61798-0","journal-title":"Lancet"},{"key":"6295_CR44","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.arth.2020.04.078","volume":"35","author":"L Leitner","year":"2020","unstructured":"Leitner L, Posch F, Amerstorfer F et al (2020) The Dark side of Arthroplasty: competing risk analysis of failed hip and knee arthroplasty with Periprosthetic Joint infection. J Arthroplasty 35:2601\u20132606e1. https:\/\/doi.org\/10.1016\/j.arth.2020.04.078","journal-title":"J Arthroplasty"},{"key":"6295_CR45","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmi.2018.04.035","volume":"25","author":"C Triffault-Fillit","year":"2019","unstructured":"Triffault-Fillit C, Ferry T, Laurent F et al (2019) Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study. Clin Microbiol Infect 25:353\u2013358. https:\/\/doi.org\/10.1016\/j.cmi.2018.04.035","journal-title":"Clin Microbiol Infect"},{"key":"6295_CR46","doi-asserted-by":"publisher","first-page":"ofaa068","DOI":"10.1093\/ofid\/ofaa068","volume":"7","author":"L Manning","year":"2020","unstructured":"Manning L, Metcalf S, Clark B et al (2020) Clinical characteristics, etiology, and initial management strategy of newly diagnosed Periprosthetic Joint infection: a Multicenter, prospective observational cohort study of 783 patients. Open Forum Infect Dis 7:ofaa068. https:\/\/doi.org\/10.1093\/ofid\/ofaa068","journal-title":"Open Forum Infect Dis"},{"key":"6295_CR47","doi-asserted-by":"publisher","first-page":"230949901984776","DOI":"10.1177\/2309499019847768","volume":"27","author":"Y Tsai","year":"2019","unstructured":"Tsai Y, Chang C-H, Lin Y-C et al (2019) Different microbiological profiles between hip and knee prosthetic joint infections. J Orthop Surg (Hong Kong) 27:2309499019847768. https:\/\/doi.org\/10.1177\/2309499019847768","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"6295_CR48","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1093\/jac\/dkx265","volume":"72","author":"M Gonzalez Moreno","year":"2017","unstructured":"Gonzalez Moreno M, Trampuz A, Di Luca M (2017) Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis. J Antimicrob Chemother 72:3085\u20133092. https:\/\/doi.org\/10.1093\/jac\/dkx265","journal-title":"J Antimicrob Chemother"},{"key":"6295_CR49","doi-asserted-by":"publisher","unstructured":"Steadman W, Chapman P, Schuetz M et al (2023) Local antibiotic delivery options in prosthetic joint infection. https:\/\/doi.org\/10.3390\/antibiotics12040752. ANTIBIOTICS-BASEL 12:","DOI":"10.3390\/antibiotics12040752"},{"key":"6295_CR50","doi-asserted-by":"publisher","first-page":"e1900224","DOI":"10.2106\/JBJS.RVW.19.00224","volume":"8","author":"R Miller","year":"2020","unstructured":"Miller R, Higuera CA, Wu J et al (2020) Periprosthetic Joint Infection: a review of Antibiotic Treatment. JBJS Rev 8:e1900224. https:\/\/doi.org\/10.2106\/JBJS.RVW.19.00224","journal-title":"JBJS Rev"},{"key":"6295_CR51","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciad360","volume":"77","author":"SB Nelson","year":"2023","unstructured":"Nelson SB, Pinkney JA, Chen AF, Tande AJ (2023) Periprosthetic Joint infection: current clinical challenges. Clin Infect Dis 77:e34\u2013e45. https:\/\/doi.org\/10.1093\/cid\/ciad360","journal-title":"Clin Infect Dis"},{"key":"6295_CR52","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s10096-017-2971-2","volume":"36","author":"V Prendki","year":"2017","unstructured":"Prendki V, Ferry T, Sergent P et al (2017) Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study. Eur J Clin Microbiol Infect Dis 36:1577\u20131585. https:\/\/doi.org\/10.1007\/s10096-017-2971-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"6295_CR53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmi.2019.09.007","volume":"26","author":"R Escudero-Sanchez","year":"2020","unstructured":"Escudero-Sanchez R, Senneville E, Digumber M et al (2020) Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect 26:499\u2013505. https:\/\/doi.org\/10.1016\/j.cmi.2019.09.007","journal-title":"Clin Microbiol Infect"},{"key":"6295_CR54","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrmicro3564","volume":"13","author":"GPC Salmond","year":"2015","unstructured":"Salmond GPC, Fineran PC (2015) A century of the phage: past, present and future. Nat Rev Microbiol 13:777\u2013786. https:\/\/doi.org\/10.1038\/nrmicro3564","journal-title":"Nat Rev Microbiol"},{"key":"6295_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-virology-031413-085500","volume":"1","author":"RL Dy","year":"2014","unstructured":"Dy RL, Richter C, Salmond GPC, Fineran PC (2014) Remarkable mechanisms in microbes to resist phage infections. Annu Rev Virol 1:307\u2013331. https:\/\/doi.org\/10.1146\/annurev-virology-031413-085500","journal-title":"Annu Rev Virol"},{"key":"6295_CR56","doi-asserted-by":"publisher","first-page":"e1062590","DOI":"10.1080\/21597081.2015.1062590","volume":"5","author":"DR Roach","year":"2015","unstructured":"Roach DR, Donovan DM (2015) Antimicrobial bacteriophage-derived proteins and therapeutic applications. Bacteriophage 5:e1062590. https:\/\/doi.org\/10.1080\/21597081.2015.1062590","journal-title":"Bacteriophage"},{"key":"6295_CR57","doi-asserted-by":"publisher","unstructured":"Shahed-Al-Mahmud M, Roy R, Sugiokto FG et al (2021) Phage \u03c6AB6-Borne depolymerase combats Acinetobacter baumannii Biofilm formation and infection. Antibiot (Basel) 10. https:\/\/doi.org\/10.3390\/antibiotics10030279","DOI":"10.3390\/antibiotics10030279"},{"key":"6295_CR58","doi-asserted-by":"publisher","unstructured":"Kolenda C, Josse J, Medina M et al (2020) Evaluation of the activity of a combination of three bacteriophages alone or in Association with antibiotics on Staphylococcus aureus embedded in Biofilm or internalized in Osteoblasts. Antimicrob Agents Chemother 64. https:\/\/doi.org\/10.1128\/AAC.02231-19","DOI":"10.1128\/AAC.02231-19"},{"key":"6295_CR59","doi-asserted-by":"publisher","first-page":"e0018223","DOI":"10.1128\/mbio.00182-23","volume":"14","author":"DA Schwartz","year":"2023","unstructured":"Schwartz DA, Rodr\u00edguez-Ramos JA, Shaffer M et al (2023) Human-gut Phages Harbor Sporulation genes. mBio 14:e0018223. https:\/\/doi.org\/10.1128\/mbio.00182-23","journal-title":"mBio"},{"key":"6295_CR60","doi-asserted-by":"publisher","unstructured":"Huang Y, Wang W, Zhang Z et al (2022) Phage products for fighting Antimicrobial Resistance. https:\/\/doi.org\/10.3390\/microorganisms10071324. Microorganisms 10:","DOI":"10.3390\/microorganisms10071324"},{"key":"6295_CR61","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/s41564-022-01207-8","volume":"7","author":"J Garb","year":"2022","unstructured":"Garb J, Lopatina A, Bernheim A et al (2022) Multiple phage resistance systems inhibit infection via SIR2-dependent NAD(+) depletion. Nat Microbiol 7:1849\u20131856. https:\/\/doi.org\/10.1038\/s41564-022-01207-8","journal-title":"Nat Microbiol"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-024-06295-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00264-024-06295-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-024-06295-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T19:02:13Z","timestamp":1729364533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00264-024-06295-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["6295"],"URL":"https:\/\/doi.org\/10.1007\/s00264-024-06295-1","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"value":"0341-2695","type":"print"},{"value":"1432-5195","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"21 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that this research was conducted in the absence of any financial interests or personal relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}